We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome (immunoprop)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01893619
Recruitment Status : Unknown
Verified July 2013 by New York CFS Association.
Recruitment status was:  Recruiting
First Posted : July 9, 2013
Last Update Posted : July 25, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Observational study regarding the use of supplements in chronic fatigue syndrome patients

Condition or disease
Chronic Fatigue Syndrome

Detailed Description:
Detailed questionnaire regarding the diagnosis of an onset of chronic fatigue syndrome and 100 patients. using Karnofsky scale before and after use of supplements patient scores are compared in a double blind trial.

Study Design

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome
Study Start Date : June 2013
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Karnovsky score comparison [ Time Frame: Six months ]
    Review of Karnofsky score over prior to diagnosis and subsequent to patients having taken supplements


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection
Criteria

Inclusion Criteria:

  • Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection

Exclusion Criteria:

  • non inclusion in the above criteria
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01893619


Locations
United States, New York
Me/Cfs Center,860 Fifth Avenue Recruiting
New York, New York, United States, 10065
Contact: derek enlander, MD    212-794-2000    denlander@aol.com   
Principal Investigator: derek enlander, md         
Sponsors and Collaborators
New York CFS Association
Investigators
Principal Investigator: DEREK enlander CFIDS RESEARCH FOUNDATION
More Information

Responsible Party: New York CFS Association
ClinicalTrials.gov Identifier: NCT01893619     History of Changes
Other Study ID Numbers: immunoprop
First Posted: July 9, 2013    Key Record Dates
Last Update Posted: July 25, 2013
Last Verified: July 2013

Keywords provided by New York CFS Association:
Chronic fatigue syndrome
Karnofsky score
supplements

Additional relevant MeSH terms:
Syndrome
Fatigue
Fatigue Syndrome, Chronic
Disease
Pathologic Processes
Signs and Symptoms
Virus Diseases
Muscular Diseases
Musculoskeletal Diseases
Encephalomyelitis
Central Nervous System Diseases
Nervous System Diseases
Neuromuscular Diseases